检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]辽宁中医药大学,辽宁沈阳110032 [2]辽宁中医药大学附属医院,辽宁沈阳110032
出 处:《中医临床研究》2019年第14期23-26,共4页Clinical Journal Of Chinese Medicine
摘 要:从中医角度来说,冠状动脉粥样硬化性心脏病(简称“冠心病”)常被称为“胸痹”等。高脂血症从其发病的病因病机及临床表现来看,可大致归类为“痰浊、血浊、膏浊”等范畴。当今社会,冠心病合并高脂血症的患者逐年增多,李文杰教授从事相关工作数十年,经验颇丰。文章通过对冠状动脉粥样硬化性心脏病及高脂血症的认识,从中医角度进行分析,以痰浊瘀阻为主要病因病机,以健脾化痰、行气散瘀为基本治疗原则,并结合基础的西医治疗,介绍了李教授对于此类疾病的分析及临床经验。In TCM, coronary heart disease is often referred to as Xiongbi (胸痹), it was roughly classified as Tanzhuo (痰浊), Xuezhuo (血浊) and Gaozhuo (膏浊) based on its etiology, pathogenesis and clinical manifestations. In today’s society, patients with coronary heart disease and hyperlipidemia are increasing year by year. Professor Li Wenjie has been engaged in related work for decades. According to the understanding of heart disease and hyperlipidemia from the perspective of etiology of TCM, the main cause of disease pathogenesis was Tanzhuo Yuzu (痰浊瘀阻);the basic treatment was Jianpi Huatan (健脾化痰) and Xingqi Sanyu (行气散瘀). Professor Li’s analysis and clinical experience in treating coronary heart disease with hyperlipidemia were introduced.
关 键 词:冠状动脉粥样硬化性心脏病 高脂血症 痰浊瘀阻 经验
分 类 号:R256.2[医药卫生—中医内科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.112